Investigation of the Role of Dinutuximab Beta-Based Immunotherapy in the SIOPEN High-Risk Neuroblastoma 1 Trial (HR-NBL1)
暂无分享，去创建一个
M. Gaze | U. Pötschger | T. Trahair | J. Michon | R. Luksch | R. Ladenstein | G. Laureys | A. Garaventa | P. Brock | H. Lode | D. Valteau‐Couanet | H. Loibner | V. Castel | A. Pearson | M. Castellani | K. Holmes | M. Beck-Popovic | E. Ruud | H. Schroeder | S. Ash | C. Owens | P. Ambros | G. Schreier | Godfrey Chi Fung Chan